Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome [PDF]
Background: Minimally invasive surfactant therapy (MIST) is a new mode of surfactant administration without intubation to spontaneously breathing preterm infants with respiratory distress syndrome (RDS).
Xing-An Wang +4 more
doaj +6 more sources
Impact of delayed cord clamping and minimally invasive surfactant administration on outcomes in premature infants with neonatal respiratory distress syndrome at less than 30 weeks gestation: a NICU quality improvement study [PDF]
BackgroundPreventing early invasive mechanical ventilation (IMV) in preterm infants is critical for reducing bronchopulmonary dysplasia (BPD) and improving outcomes.
Yijia Zhang +8 more
doaj +6 more sources
Comparison of Minimally Invasive Surfactant Therapy and Intubation-surfactant Administration-extubation in Premature Neonates with Respiratory Distress Syndrome [PDF]
Objectives: Surfactant therapy is an established treatment for neonatal respiratory distress syndrome (RDS). We sought to compare two administration techniques, intubation-surfactant administration-extubation (INSURE) and minimally invasive surfactant ...
Mehrdad Rezaei +5 more
doaj +6 more sources
Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China [PDF]
Background/Aims: Nasal continuous positive airway pressure (nCPAP) was recommended as the initial respiratory support for spontaneous breathing in infants with very low birth weight and neonatal respiratory distress syndrome (NRDS).
Tongyan Han +21 more
doaj +5 more sources
A multicenter, randomized controlled, non-inferiority trial, comparing nasal continuous positive airway pressure with nasal intermittent positive pressure ventilation as primary support before minimally invasive surfactant administration for preterm infants with respiratory distress syndrome (the NIV-MISA-RDS trial): Study protocol [PDF]
BackgroundNon-invasive ventilation (NIV) treatment has been developed to minimize lung damage and to avoid invasive mechanical ventilation (IMV) in preterm infants, especially in those with a gestational age of <30 weeks.
Hui Zhang +6 more
doaj +4 more sources
Non-Invasive Surfactant Administration in Preterm Infants [PDF]
Background: Although surfactant replacement therapy has been a cornerstone of respiratory distress syndrome (RDS) management for decades, traditional delivery via endotracheal intubation and mechanical ventilation is associated with procedure-related ...
Faten Budajaja +2 more
doaj +3 more sources
Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial [PDF]
Background Respiratory distress syndrome (RDS) is a common cause of hospitalization and death in preterm infants who require surfactant treatment and respiratory support.
Mohammad Kazem Sabzehei +4 more
doaj +6 more sources
Minimally invasive surfactant administration in extremely preterm infants <28 weeks gestation with spontaneous breathing: a retrospective quality improvement study on reducing invasive ventilation burden [PDF]
BackgroundInvasive surfactant delivery via endotracheal intubation increases exposure to invasive mechanical ventilation (IMV) in extremely preterm infants (EPIs, <28 weeks). This quality improvement (QI) initiative aimed to evaluate whether minimally
Wenxin Dong +5 more
doaj +4 more sources
Ultrasound evaluation of diaphragm kinetics after minimally invasive surfactant administration. [PDF]
Concerns remain on different alveolar deposition of surfactant between LISA and INSURE methods. Ultrasound evaluation of diaphragm kinetics may provide clinical evidence on this issue, as indirect representation of the respiratory system compliance.This was a prospective-observational pilot study. The inclusion criterion was CPAP-supported infants ≤ 32
Radicioni M +4 more
europepmc +3 more sources
[Risk factors for minimally invasive surfactant administration failure in preterm infants with respiratory distress syndrome]. [PDF]
To identify risk factors for minimally invasive surfactant administration (MISA) failure in the treatment of preterm infants with respiratory distress syndrome (RDS) and the influence of MISA failure on neonatal outcome.A retrospective analysis was performed for the clinical data of 148 preterm infants with a gestational age of ≤32 weeks and a clinical
Liu HQ +21 more
europepmc +3 more sources

